miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 520-526

  Wang, He Fei ^a   Chen, Hong ^b   Ma, Min Wang ^c   Wang, Ji An ^d   Tang, Ting Ting ^e   Ni, Lai Sheng ^f   Yu, Jin Ling ^g   Li, Yu Zhen ^a   Bai, Bing Xue ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^d Obstetrics and Gynecology Hospital   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Harbin Acheng District People's Hospital   (China)

^g Jixi Mining Industry Group General Hospital   (China)

Author keywords

Melanoma; Melanoma cell adhesion molecule; microRNA; miR 573

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD146 ANTIGEN; MICRORNA; MICRORNA 573; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CANCER TISSUE; CELL ASSAY; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANTIGENS, CD146; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878212410     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2451     Document Type: Article

References (21)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592, 2007.
2. Lehmann JM, Riethmuller G and Johnson JP: MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86: 9891-9895, 1989.
3. Wu GJ, Peng Q, Fu P, et al: Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene 327: 201-213, 2004.
4. Zabouo G, Imbert AM, Jacquemier J, et al: CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res 11: R1, 2009.
5. Kristiansen G, Yu Y, Schlüns K, Sers C, Dietel M and Petersen I: Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol 25: 77-81, 2003.
6. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
7. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
8. Kim VN, Han J and Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139, 2009.
9. Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
10. Glud M and Gniadecki R: MicroRNAs in the pathogenesis of malignant melanoma. J Eur Acad Dermatol Venereol 27: 142-150, 2013.
11. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
12. Mueller DW and Bosserhoff AK: Role of miRNAs in the progression of malignant melanoma. Br J Cancer 101: 551-556, 2009.
13. Mueller DW, Rehli M and Bosserhoff AK: miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-1751, 2009.
14. Noguchi S, Mori T, Otsuka Y, et al: Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 287: 11769-11777, 2012.
15. Essa S, Reichrath S, Mahlknecht U, Montenarh M, Vogt T and Reichrath J: Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res 32: 383-389, 2012.
16. Yang CH, Yue J, Pfeffer SR, Handorf CR and Pfeffer LM: MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 286: 39172-39178, 2011.
17. Hanna JA, Hahn L, Agarwal S and Rimm DL: In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Lab Invest 92: 1390-1397, 2012.
18. Cozzolino AM, Pedace L, Castori M, et al: Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening. Fam Cancer 11: 201-208, 2012.
19. Wu Z, Wu Z, Li J, Yang X, et al: MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour Biol 33: 1619-1628, 2012.
20. Liu JW, Nagpal JK, Jeronimo C, et al: Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer. Prostate 68: 418-426, 2008.
21. Wu GJ, Fu P, Wang SW and Wu MW: Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res 6: 1666-1677, 2008.